Jefferies Raises Price Target on Vertex Pharma (VRTX) to $107; Reiterates Buy
Tweet Send to a Friend
Jefferies reiterated a Buy rating on Vertex Pharma (NASDAQ: VRTX), and raised the price target to $107.00 (from $102.00), following ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
